August 22, 2025

Nemolizumab Study Tracks 68 Weeks of Relief

A long-term clinical study finds that the biologic therapy nemolizumab, when used with topical corticosteroids, continues to improve itch, sleep, and skin symptoms in prurigo nodularis patients over 68 weeks.

Conexiant

August 21, 2025

Screen Time May Raise Cardiometabolic Risk in Youth

Researchers link increased screen time in children and adolescents to higher cardiometabolic and cardiovascular risk, with sleep duration identified as a key moderating factor.

Conexiant

August 21, 2025

Six Evidence-Based Strategies Transform Clinical Listening

New research identifies six practical approaches to values-driven listening that enhance patient trust, reduce burnout, and improve care quality.

Conexiant

August 20, 2025

Genes and Environment Shape Infant Sleep Patterns: Study

Twin study reveals how hereditary factors increasingly dominate infant behavior patterns during critical early months of development.

Conexiant

August 20, 2025

One Hour on Phone, Fewer Blinks

Blinking decreases and eye strain increases during one hour of smartphone use, with dynamic screen changes from social media reels creating the highest visual load.

Conexiant

August 20, 2025

Key Stressors Identified in UK Dental Teams

 Researchers stress the importance of systemic change, rather than individual resilience resources.

Conexiant

August 20, 2025

Can a Smartwatch Help Fight Burnout?

Physicians wearing smartwatches with access to their physiological data show reduced burnout and improved resilience after six months of use.

Conexiant

August 19, 2025

‘Enough Is Enough’—But When?

How Bogalusa, Louisiana became a lens on the US gun violence epidemic—where race, poverty, policy, and profit converge and communities bear the cost.

KFF Health News

August 19, 2025

Bedtime Cyclobenzaprine Relieves Fibromyalgia: Randomized Trial

Researchers found bedtime sublingual cyclobenzaprine reduced pain versus placebo and improved sleep, fatigue, and function with mostly mild oral adverse events.

Conexiant